Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 27 May | 529.60 |
-5.90 (-1.10%) |
OPEN
535.50 |
HIGH
543.00 |
LOW
524.50 |
NSE 00:00 | 27 May | 529.70 |
-6.15 (-1.15%) |
OPEN
540.00 |
HIGH
543.20 |
LOW
525.00 |
OPEN | 535.50 |
PREVIOUS CLOSE | 535.50 |
VOLUME | 121279 |
52-Week high | 1038.30 |
52-Week low | 514.50 |
P/E | 20.35 |
Mkt Cap.(Rs cr) | 31,029 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Balance Sheet
Figures in Rs crore | 2021 | 2020 | 2019 |
Sources of Funds | |||
Share Capital | 58.59 | 58.59 | 58.59 |
Reserves | 15866.02 | 12993.91 | 11292.03 |
Total Shareholders Funds | 15924.61 | 13052.50 | 11350.62 |
Secured Loans | 841.50 | 1314.36 | 1594.43 |
Unsecured Loans | 3186.02 | 2469.78 | 2948.01 |
Total Debt | 4027.52 | 3784.14 | 4542.44 |
Total Liabilities | 19952.13 | 16836.64 | 15893.06 |
Application of Funds | |||
Gross Block | 6688.91 | 6180.91 | 5446.15 |
Capital Work in Progress | 734.89 | 814.85 | 789.01 |
Investments | 5009.93 | 2527.41 | 2339.06 |
Current Assets, Loans & Advances | |||
Inventories | 4841.38 | 4359.57 | 3971.26 |
Sundry Debtors | 5928.01 | 5785.00 | 5232.07 |
Cash and Bank | 386.18 | 86.16 | 75.77 |
Loans and Advances | 1885.14 | 1984.74 | 2023.72 |
Total Current Assets | 13040.71 | 12215.47 | 11302.82 |
Current Liabilities and Provisions | |||
Current Liabilities | 3055.46 | 3023.62 | 2591.02 |
Provisions | 250.01 | 115.27 | 96.51 |
Net Current Assets | 9735.24 | 9076.58 | 8615.29 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | N/A | N/A | N/A |
Deferred Tax Liability | N/A | N/A | N/A |
Net Deferred Tax | N/A | N/A | N/A |
Other Assets | 0.00 | 0.00 | 0.00 |
Total Assets | 19952.13 | 16836.64 | 15893.06 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices